SPY367.70+0.91 0.25%
DIA300.88+1.70 0.57%
IXIC12,408.61+59.24 0.48%

Raymond James Maintains Strong Buy on Mirum Pharmaceuticals, Raises Price Target to $52

Raymond James maintains Mirum Pharmaceuticals (NASDAQ:MIRM) with a Strong Buy and raises the price target from $48 to $52.

· 11/13/2020 07:22
Raymond James maintains Mirum Pharmaceuticals (NASDAQ:MIRM) with a Strong Buy and raises the price target from $48 to $52.